Carfilzomib (PR-171)
Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the ?5 subunit, but little or no effect on the PGPH and T-L activities.
